Skip to main content
. Author manuscript; available in PMC: 2022 Jul 13.
Published in final edited form as: Immunity. 2021 May 20;54(7):1392–1404.e10. doi: 10.1016/j.immuni.2021.04.024

Figure 2. Binding of CARD8-CT at Site B Which is Not Disrupted by DPP9 Inhibitors.

Figure 2.

(A) Superimposition of the ZU5A-UPAA relationship onto UPAB to generate a theoretical ZU5B (purple). A theoretical ZU5B cannot be accommodated by the structure, explaining why site B is a dissociated UPAB, rather than a complete FIIND.

(B) Cryo-EM density of the DPP9-CARD8 (S297A) complex with no visible UPAB density. Autoproteolysis, and presumably, N-terminal degradation is required for site B association.

(C) Density of the DPP9-CARD8 complex near the DPP9 active site.

(D) Zoom-in of the DPP9 substrate tunnel in the DPP9-CARD8 complex. CARD8-UPAB binds near, but not into, the DPP9 substrate tunnel and the R-helix remains disordered. In comparison, zoom-in view of the NLRP1-DPP9 complex (PDB ID: 6X6A) at the DPP9 active site shows occupancy by the NLRP1-CT peptide.

(E) Density of the DPP9-CARD8 complex with bound VbP near the active site.

(F) Zoom-in of the DPP9 substrate tunnel in the DPP9-CARD8 complex with VbP. VbP binds near the active site, causing R-helix ordering, but does not displace CARD8-UPAB. in comparison, zoom-in view of the NLRP1-DPP9-VbP complex (PDB ID: 6X6C) at the DPP9 active site shows that VbP displaces the NLRP1-CT peptide.

See also Figure S3 and S4, and Table S1.